Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Joy Tang | F | - |
Markable, Inc.
 Markable, Inc. Packaged SoftwareTechnology Services Markable, Inc. develops a visual search technology in fashion that connects photos and products. It allows users to spot a photo from a social network, phone gallery, and freshly snapped; mark the product; find the product or the best matches; and to purchase the product. The company was founded Joy Tang in 2013 and is headquartered in Madison, WI. | 8 years |
| Brent A. Vaughan | M | - |
Cognito Therapeutics, Inc.
 Cognito Therapeutics, Inc. BiotechnologyHealth Technology Cognito Therapeutics, Inc. is a clinical-stage neurotechnology company based in Cambridge, MA. Cognito Therapeutics is developing disease-modifying therapeutic approaches to treat neurodegenerative disorders using its non-invasive neuromodulation platform. The company's lead therapy is currently in a pivotal study (HOPE) in Alzheimer's disease and has been awarded FDA breakthrough device designation. Cognito Therapeutics is advancing the field of neuromodulation to create novel therapeutics that improve the lives of patients living with neurodegenerative diseases. The company was founded by Li-Huei Tsai and Ed Boyden, and Brent A. Vaughan has been the CEO of the company since 2020. | 4 years |
| Deepak Garg | M | - | - | |
| Richard Kuntz | M | 66 |
Cognito Therapeutics, Inc.
Cognito Therapeutics, Inc. BiotechnologyHealth Technology Cognito Therapeutics, Inc. is a clinical-stage neurotechnology company based in Cambridge, MA. Cognito Therapeutics is developing disease-modifying therapeutic approaches to treat neurodegenerative disorders using its non-invasive neuromodulation platform. The company's lead therapy is currently in a pivotal study (HOPE) in Alzheimer's disease and has been awarded FDA breakthrough device designation. Cognito Therapeutics is advancing the field of neuromodulation to create novel therapeutics that improve the lives of patients living with neurodegenerative diseases. The company was founded by Li-Huei Tsai and Ed Boyden, and Brent A. Vaughan has been the CEO of the company since 2020. | 1 years |
| Stephen Bruso | M | - |
Cognito Therapeutics, Inc.
Cognito Therapeutics, Inc. BiotechnologyHealth Technology Cognito Therapeutics, Inc. is a clinical-stage neurotechnology company based in Cambridge, MA. Cognito Therapeutics is developing disease-modifying therapeutic approaches to treat neurodegenerative disorders using its non-invasive neuromodulation platform. The company's lead therapy is currently in a pivotal study (HOPE) in Alzheimer's disease and has been awarded FDA breakthrough device designation. Cognito Therapeutics is advancing the field of neuromodulation to create novel therapeutics that improve the lives of patients living with neurodegenerative diseases. The company was founded by Li-Huei Tsai and Ed Boyden, and Brent A. Vaughan has been the CEO of the company since 2020. | - |
| Jiang Yvonne | F | - |
Foundersx LLC
 Foundersx LLC Investment ManagersFinance Foundersx LLC (FoundersX) is a venture capital firm founded in 2016 by Helen H. Liang. The firm is headquartered in Menlo Park, California. | - |
| Leo (Naiwen) Cui | M | - |
Foundersx LLC
Foundersx LLC Investment ManagersFinance Foundersx LLC (FoundersX) is a venture capital firm founded in 2016 by Helen H. Liang. The firm is headquartered in Menlo Park, California. | 2 years |
| Harman Sandhu | M | - | - | |
| Zach Malcano | M | - |
Cognito Therapeutics, Inc.
Cognito Therapeutics, Inc. BiotechnologyHealth Technology Cognito Therapeutics, Inc. is a clinical-stage neurotechnology company based in Cambridge, MA. Cognito Therapeutics is developing disease-modifying therapeutic approaches to treat neurodegenerative disorders using its non-invasive neuromodulation platform. The company's lead therapy is currently in a pivotal study (HOPE) in Alzheimer's disease and has been awarded FDA breakthrough device designation. Cognito Therapeutics is advancing the field of neuromodulation to create novel therapeutics that improve the lives of patients living with neurodegenerative diseases. The company was founded by Li-Huei Tsai and Ed Boyden, and Brent A. Vaughan has been the CEO of the company since 2020. | - |
| Gerald Chan | M | - |
Cognito Therapeutics, Inc.
Cognito Therapeutics, Inc. BiotechnologyHealth Technology Cognito Therapeutics, Inc. is a clinical-stage neurotechnology company based in Cambridge, MA. Cognito Therapeutics is developing disease-modifying therapeutic approaches to treat neurodegenerative disorders using its non-invasive neuromodulation platform. The company's lead therapy is currently in a pivotal study (HOPE) in Alzheimer's disease and has been awarded FDA breakthrough device designation. Cognito Therapeutics is advancing the field of neuromodulation to create novel therapeutics that improve the lives of patients living with neurodegenerative diseases. The company was founded by Li-Huei Tsai and Ed Boyden, and Brent A. Vaughan has been the CEO of the company since 2020. | - |
| John Sun | M | - |
Foundersx LLC
Foundersx LLC Investment ManagersFinance Foundersx LLC (FoundersX) is a venture capital firm founded in 2016 by Helen H. Liang. The firm is headquartered in Menlo Park, California. | - |
| Lok Chung Chan | M | 73 |
Cognito Therapeutics, Inc.
Cognito Therapeutics, Inc. BiotechnologyHealth Technology Cognito Therapeutics, Inc. is a clinical-stage neurotechnology company based in Cambridge, MA. Cognito Therapeutics is developing disease-modifying therapeutic approaches to treat neurodegenerative disorders using its non-invasive neuromodulation platform. The company's lead therapy is currently in a pivotal study (HOPE) in Alzheimer's disease and has been awarded FDA breakthrough device designation. Cognito Therapeutics is advancing the field of neuromodulation to create novel therapeutics that improve the lives of patients living with neurodegenerative diseases. The company was founded by Li-Huei Tsai and Ed Boyden, and Brent A. Vaughan has been the CEO of the company since 2020. | 3 years |
| Wendy Hayes | F | 54 |
Foundersx LLC
Foundersx LLC Investment ManagersFinance Foundersx LLC (FoundersX) is a venture capital firm founded in 2016 by Helen H. Liang. The firm is headquartered in Menlo Park, California. | 4 years |
| Sheng Fu | M | - |
Markable, Inc.
Markable, Inc. Packaged SoftwareTechnology Services Markable, Inc. develops a visual search technology in fashion that connects photos and products. It allows users to spot a photo from a social network, phone gallery, and freshly snapped; mark the product; find the product or the best matches; and to purchase the product. The company was founded Joy Tang in 2013 and is headquartered in Madison, WI. | - |
| Mashal Dhawan | F | - | - | |
| Jessica Koh | F | - |
Foundersx LLC
Foundersx LLC Investment ManagersFinance Foundersx LLC (FoundersX) is a venture capital firm founded in 2016 by Helen H. Liang. The firm is headquartered in Menlo Park, California. | 8 years |
| Tom Kosnik | M | - |
Foundersx LLC
Foundersx LLC Investment ManagersFinance Foundersx LLC (FoundersX) is a venture capital firm founded in 2016 by Helen H. Liang. The firm is headquartered in Menlo Park, California. | 8 years |
| Sizi Chen | F | - |
Foundersx LLC
Foundersx LLC Investment ManagersFinance Foundersx LLC (FoundersX) is a venture capital firm founded in 2016 by Helen H. Liang. The firm is headquartered in Menlo Park, California. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Hodes Cyrus | M | - |
Foundersx LLC
Foundersx LLC Investment ManagersFinance Foundersx LLC (FoundersX) is a venture capital firm founded in 2016 by Helen H. Liang. The firm is headquartered in Menlo Park, California. | 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 16 | 84.21% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Helen Liang
- Personal Network
